Alantra advised Lydall on the sale of Charter Medical
SECTORHealthcare; Industrials
ServiceM&A
Value $29.9 million
Alantra advised Lydall, Inc. (NYSE:LDL) on the sale of Charter Medical Ltd. to a US subsidiary of Fenner PLC (LSE:FENR), for $29.9 million
Related Transactions
-
Jan 2021Sell-side advisoryJan 2021SECTOR HealthcareService M&A
-
Jan 2021Sell-side advisoryJan 2021SECTOR HealthcareService M&A
-
Dec 2020Debt financingValue €50 millionDec 2020SECTOR HealthcareService Debt AdvisoryValue €50 million
-
Nov 2020Buy-side advisoryNov 2020SECTOR HealthcareService M&A